Wei, L <br/><br/>
[Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir combined with ribavirin in Asian adult patients with chronic HCV genotype 1b infection and compensated cirrhosis].  [electronic resource] 

 -  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology  May 2018 
 - 353-358 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1007-3418 
<br/><br/><label>Standard No.: </label>10.3760/cma.j.issn.1007-3418.2018.05.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Adult<br/>Anilides<br/>Antiviral Agents<br/>Carbamates<br/>Cyclopropanes<br/>Drug Therapy, Combination<br/>Genotype<br/>Hepacivirus<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Lactams, Macrocyclic<br/>Liver Cirrhosis<br/>Macrocyclic Compounds<br/>Proline--analogs & derivatives<br/>Ribavirin<br/>Ritonavir<br/>Sulfonamides<br/>Uracil--analogs & derivatives<br/>Valine